Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis

Completed · Not applicable · Has a placebo group

Conditions studied: Gastroparesis With Diabetes Mellitus

In brief

The device being studied, the Transcutaneous Electrical Accustimulator (TEA), will deliver weak electrical current at two specific points, one at the leg and the other at the arm at settings known to improve symptoms involving the digestive system. The study team would like to test if the device will impact the gastrointestinal (GI) symptoms and gastric motility in study participants with gastroparesis.

Key facts

Study ID
NCT05362578
Run by
University of Michigan
People needed
41
Starts
2022-09-08
Expected to finish
2025-02-28
Last updated by the study team
2026-07-20

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.